CROMSOURCE, an international contract research organization (CRO), has announced consolidation of its Hybrid Services Model. Due to client demand, CROMSOURCE has further refined its Hybrid Services to be able to provide its pharmaceutical, medical device, and biotechnology clients with an efficient alternative to traditional fully outsourced or functional service provider (FSP) models.
Download this press release
On March 1st, 2023 ClinChoice acquired CROMSOURCE, strengthening its global network and deepening its full-service capabilities. Strategically, the acquisition will expand ClinChoice’s coverage in Europe and in US to better meet its global clients’ needs in clinical development and staffing solution services. This merger also expands its data science technology offerings in many areas including decentralized clinical trials and risk-based monitoring.
